Tolvaptan (JYNARQUE)
Vasopressin V2 Receptor Antagonist class · 6 generic manufacturers · 21 ANDAs filed at FDA.
$227.8M in CY2024 Part D spend21K claims · 4K beneficiaries · 329 plans surveyed
Questions a plan sponsor actually asks.
What is Tolvaptan used for?
Tolvaptan is tracked in Medicare Part D. Specific indication information is not available in our current dataset.
Is there a generic for Tolvaptan?
Yes. 21 ANDAs filed at FDA, 6 generic manufacturers currently shipping.
How much does my plan pay for Tolvaptan?
Across 329 Part D plans, Tolvaptan averages $14.57/unit (NADAC). Lowest available: $14.57/unit. Highest in distribution: $14.57/unit.
Is Tolvaptan on the FDA shortage list?
No. Tolvaptan is not currently on the FDA Drug Shortage Database.
6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (7 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.